S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   266.87 (-1.28%)
AAPL   106.84 (-3.17%)
MSFT   200.39 (-1.24%)
FB   252.53 (-0.90%)
GOOGL   1,451.09 (-2.42%)
AMZN   2,954.91 (-1.79%)
NVDA   487.57 (-2.20%)
TSLA   442.15 (+4.42%)
BABA   272.41 (-1.20%)
CGC   16.36 (-0.24%)
GE   6.88 (-2.41%)
MU   50.74 (-0.47%)
AMD   74.93 (-2.12%)
T   28.93 (-0.48%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   469.96 (-0.05%)
DIS   128.63 (-1.22%)
BAC   25.21 (-0.55%)
BA   161.14 (-3.81%)
Log in
NASDAQ:CYRX

CryoPort Stock Forecast, Price & News

$46.03
+0.43 (+0.94 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$44.96
Now: $46.03▼
$47.02
50-Day Range
$31.04
MA: $43.16▼
$57.99
52-Week Range
$12.40
Now: $46.03▼
$60.82
Volume1.08 million shs
Average Volume633,867 shs
Market Capitalization$1.78 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.31
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Read More
CryoPort logo

Beat the Market (BTM) Rank™

Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.17 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorTransportation
Current SymbolNASDAQ:CYRX
Previous Symbol
CUSIPN/A
CIK1124524
Webwww.cryoport.com
Phone949-470-2300

Debt

Debt-to-Equity Ratio0.92
Current Ratio22.95
Quick Ratio22.89

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$33.94 million
Price / Sales52.59
Cash FlowN/A
Price / Cash FlowN/A
Book Value$3.52 per share
Price / Book13.08

Profitability

EPS (Most Recent Fiscal Year)($0.55)
Net Income$-18,330,000.00
Net Margins-60.97%
Return on Equity-18.89%
Return on Assets-13.96%

Miscellaneous

EmployeesN/A
Outstanding Shares38,778,000
Market Cap$1.78 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$46.03
+0.43 (+0.94 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CryoPort (NASDAQ:CYRX) Frequently Asked Questions

How has CryoPort's stock been impacted by COVID-19?

CryoPort's stock was trading at $16.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CYRX shares have increased by 177.0% and is now trading at $46.03.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of CryoPort?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CryoPort.

When is CryoPort's next earnings date?

CryoPort is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for CryoPort.

How were CryoPort's earnings last quarter?

CryoPort Inc (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, August, 6th. The consumer goods maker reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.04. The consumer goods maker earned $9.39 million during the quarter, compared to analyst estimates of $8.93 million. CryoPort had a negative return on equity of 18.89% and a negative net margin of 60.97%. The company's revenue for the quarter was up 11.0% on a year-over-year basis. During the same period last year, the firm earned ($0.08) EPS.
View CryoPort's earnings history.

What price target have analysts set for CYRX?

6 equities research analysts have issued 1-year price targets for CryoPort's stock. Their forecasts range from $25.00 to $66.00. On average, they expect CryoPort's stock price to reach $42.33 in the next year. This suggests that the stock has a possible downside of 8.0%.
View analysts' price targets for CryoPort.

Are investors shorting CryoPort?

CryoPort saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 6,420,000 shares, a drop of 18.5% from the August 15th total of 7,880,000 shares. Based on an average daily trading volume, of 784,300 shares, the days-to-cover ratio is presently 8.2 days.
View CryoPort's Short Interest.

Who are some of CryoPort's key competitors?

Some companies that are related to CryoPort include ACADIA Pharmaceuticals (ACAD), Perrigo (PRGO), Bausch Health Companies (BHC), Emergent Biosolutions (EBS), BridgeBio Pharma (BBIO), Ultragenyx Pharmaceutical (RARE), United Therapeutics (UTHR), Zai Lab (ZLAB), HUTCHISON CHINA/S (HCM), Arrowhead Pharmaceuticals (ARWR), Blueprint Medicines (BPMC), Legend Biotech (LEGN), Allakos (ALLK), Arena Pharmaceuticals (ARNA) and FibroGen (FGEN).
View all competitors.

What other stocks do shareholders of CryoPort own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), Taiwan Semiconductor Mfg. (TSM), NVIDIA (NVDA), Amarin (AMRN), Crispr Therapeutics (CRSP), Enterprise Products Partners (EPD), Exelixis (EXEL) and Sorrento Therapeutics (SRNE).

Who are CryoPort's key executives?

CryoPort's management team includes the following people:
  • Jerrell W. Shelton, Chairman, President & Chief Executive Officer
  • Phil Wilson, SVP-Global Operations & Supply Chain
  • Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
  • Bret Bollinger, Chief Technology Officer
  • Mark W. Sawicki, Chief Commercial Officer

What is CryoPort's stock symbol?

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

Who are CryoPort's major shareholders?

CryoPort's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.34%), Victory Capital Management Inc. (2.68%), TimesSquare Capital Management LLC (1.99%), GW&K Investment Management LLC (1.79%), FMR LLC (1.02%) and Granite Investment Partners LLC (0.99%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for CryoPort.

Which major investors are selling CryoPort stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., TimesSquare Capital Management LLC, Creative Planning, Essex Investment Management Co. LLC, Silvercrest Asset Management Group LLC, Handelsbanken Fonder AB, Taylor Wealth Management Partners, and Penbrook Management LLC. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for CryoPort.

Which major investors are buying CryoPort stock?

CYRX stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Granite Investment Partners LLC, Bamco Inc. NY, SG Americas Securities LLC, Great Lakes Advisors LLC, Vanguard Group Inc., Artal Group S.A., and Marshall Wace LLP.
View insider buying and selling activity for CryoPort.

How do I buy shares of CryoPort?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CryoPort's stock price today?

One share of CYRX stock can currently be purchased for approximately $46.03.

How big of a company is CryoPort?

CryoPort has a market capitalization of $1.78 billion and generates $33.94 million in revenue each year. The consumer goods maker earns $-18,330,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

What is CryoPort's official website?

The official website for CryoPort is www.cryoport.com.

How can I contact CryoPort?

CryoPort's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.